93 related articles for article (PubMed ID: 9191303)
21. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
22. Expression of MHC class II antigens on human glioma cells modulated by transfection with genes encoding these antigens.
Yoshida S; Takahashi H; Tanaka R
Neurol Med Chir (Tokyo); 1991 Oct; 31(10):623-8. PubMed ID: 1725809
[TBL] [Abstract][Full Text] [Related]
23. Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain.
Sekaly RP; Tonnelle C; Strubin M; Mach B; Long EO
J Exp Med; 1986 Nov; 164(5):1490-504. PubMed ID: 2430042
[TBL] [Abstract][Full Text] [Related]
24. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments.
Bakke O; Dobberstein B
Cell; 1990 Nov; 63(4):707-16. PubMed ID: 2121367
[TBL] [Abstract][Full Text] [Related]
25. Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion.
Neumann J; Eis-Hübinger AM; Koch N
J Immunol; 2003 Sep; 171(6):3075-83. PubMed ID: 12960333
[TBL] [Abstract][Full Text] [Related]
26. Distinct intracellular compartments involved in invariant chain degradation and antigenic peptide loading of major histocompatibility complex (MHC) class II molecules.
Ferrari G; Knight AM; Watts C; Pieters J
J Cell Biol; 1997 Dec; 139(6):1433-46. PubMed ID: 9396749
[TBL] [Abstract][Full Text] [Related]
27. HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides.
Muntasell A; Carrascal M; Serradell L; Veelen Pv Pv; Verreck F; Koning F; Raposo G; Abián J; Jaraquemada D
J Immunol; 2002 Nov; 169(9):5052-60. PubMed ID: 12391221
[TBL] [Abstract][Full Text] [Related]
28. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY.
Szöllósi J; Horejsí V; Bene L; Angelisová P; Damjanovich S
J Immunol; 1996 Oct; 157(7):2939-46. PubMed ID: 8816400
[TBL] [Abstract][Full Text] [Related]
29. Conformational variation of surface class II MHC proteins during myeloid dendritic cell differentiation accompanies structural changes in lysosomal MIIC.
Potolicchio I; Chitta S; Xu X; Fonseca D; Crisi G; Horejsi V; Strominger JL; Stern LJ; Raposo G; Santambrogio L
J Immunol; 2005 Oct; 175(8):4935-47. PubMed ID: 16210595
[TBL] [Abstract][Full Text] [Related]
30. Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction.
Lu Y; Boss JM; Hu SX; Xu HJ; Blanck G
J Immunol; 1996 Apr; 156(7):2495-502. PubMed ID: 8786310
[TBL] [Abstract][Full Text] [Related]
31. Induction of HLA-DR antigen on human squamous carcinoma by recombinant interferon gamma.
Koch WM; Dugan E; Diaz LA; Richtsmeier WJ
Laryngoscope; 1988 May; 98(5):511-5. PubMed ID: 3129628
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor.
Hornell TM; Beresford GW; Bushey A; Boss JM; Mellins ED
J Immunol; 2003 Sep; 171(5):2374-83. PubMed ID: 12928384
[TBL] [Abstract][Full Text] [Related]
33. Interaction of HLA-DR and CD74 at the cell surface of antigen-presenting cells by single particle image analysis.
Karakikes I; Morrison IE; O'Toole P; Metodieva G; Navarrete CV; Gomez J; Miranda-Sayago JM; Cherry RJ; Metodiev M; Fernandez N
FASEB J; 2012 Dec; 26(12):4886-96. PubMed ID: 22889831
[TBL] [Abstract][Full Text] [Related]
34. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
Hitzel C; van Endert P; Koch N
J Immunol; 1995 Feb; 154(3):1048-56. PubMed ID: 7822782
[TBL] [Abstract][Full Text] [Related]
35. Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells.
Morimoto Y; Toyota M; Satoh A; Murai M; Mita H; Suzuki H; Takamura Y; Ikeda H; Ishida T; Sato N; Tokino T; Imai K
Br J Cancer; 2004 Feb; 90(4):844-52. PubMed ID: 14970863
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus infection of CR2-transfected epithelial cells reveals the presence of MHC class II on the virion.
Knox PG; Young LS
Virology; 1995 Oct; 213(1):147-57. PubMed ID: 7483258
[TBL] [Abstract][Full Text] [Related]
37. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
[TBL] [Abstract][Full Text] [Related]
38. Regulation of the expression of class II genes of the human major histocompatibility complex in tumor cells.
Gambari R; Barbieri R; Piva R; Tecce R; Fisher PB; Giacomini P; Natali PG
Ann N Y Acad Sci; 1987; 511():292-307. PubMed ID: 2449840
[TBL] [Abstract][Full Text] [Related]
39. Regulation of MHC class II antigen presentation by sorting of recycling HLA-DM/DO and class II within the multivesicular body.
van Lith M; van Ham M; Griekspoor A; Tjin E; Verwoerd D; Calafat J; Janssen H; Reits E; Pastoors L; Neefjes J
J Immunol; 2001 Jul; 167(2):884-92. PubMed ID: 11441095
[TBL] [Abstract][Full Text] [Related]
40. Assembly and peptide binding of major histocompatibility complex class II heterodimers in an in vitro translation system.
Hedley ML; Urban RG; Strominger JL
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10479-83. PubMed ID: 7937979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
